Home › Funds › Olstein Capital Management, L.P. › DGX

Olstein Capital Management, L.P. position in DGX

QUEST DIAGNOSTICS INC · Health Care

Olstein Capital Management, L.P. reported holding 35,800 shares of DGX (QUEST DIAGNOSTICS INC) in its Q1 2026 13F filing — a position valued at US$7.0M, representing 1.53% of its reported portfolio and ranking #16 among its reported holdings. Olstein Capital Management, L.P. has disclosed DGX holdings in 11 of the last 11 reported quarters, going back to Q3 2023.

Latest position (Q1 2026)35.80K sh
Reported value held$7.02M
Portfolio Weight1.53%
First reportedQ3 2023
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Olstein Capital Management, L.P.'s DGX position evolved

Olstein Capital Management, L.P. first disclosed a stake in DGX in Q3 2023 at 68,000 shares (US$8.3M). The position peaked in Q2 2024 at 67,000 shares, worth US$9.2M. Across 11 filings, Olstein Capital Management, L.P. increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q1 2026) shows 35,800 shares valued at US$7.0M — a reduction of -4,200 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 68.00K $8.29M New
Q4 2023 58.00K $8.00M Reduce
Q1 2024 67.00K $8.92M Add
Q2 2024 67.00K $9.17M Hold
Q3 2024 55.32K $8.59M Reduce
Q4 2024 54.22K $8.18M Reduce
Q1 2025 46.00K $7.78M Reduce
Q2 2025 40.00K $7.18M Reduce
Q3 2025 40.00K $7.62M Hold
Q4 2025 40.00K $6.94M Hold
Q1 2026 35.80K $7.02M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has Olstein Capital Management, L.P. held DGX?

Olstein Capital Management, L.P. has disclosed DGX holdings in 11 of the last 11 reported quarters, going back to Q3 2023.

What is Olstein Capital Management, L.P.'s current position in DGX?

As of Q1 2026, Olstein Capital Management, L.P. holds 35.80K shares of DGX (QUEST DIAGNOSTICS INC), valued at $7.02M, representing 1.53% of its reported portfolio and ranking #16.

Has Olstein Capital Management, L.P. been buying or selling DGX?

In the latest 13F filing (Q1 2026), Olstein Capital Management, L.P. reduced its position in DGX. The position peaked in Q2 2024 at 67.00K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.